# Pleural Bleomycin vs Mechanical Abrasion in Malignant Pleural Effusion

> **NCT06691009** · NA · NOT_YET_RECRUITING · sponsor: **Assiut University** · enrollment: 70 (estimated)

## Conditions studied

- Malignant Pleural Effusion

## Interventions

- **PROCEDURE:** Group 1 (mechanical pleurodesis)
- **PROCEDURE:** Group 2 chemical pleurodesis by bleomycin)

## Key facts

- **NCT ID:** NCT06691009
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12-10
- **Primary completion:** 2029-08-10
- **Final completion:** 2029-10-10
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2024-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06691009

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06691009, "Pleural Bleomycin vs Mechanical Abrasion in Malignant Pleural Effusion". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06691009. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*